ADC Therapeutics SA
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 18 trades on this page.
Chief Medical Officer
Common Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Legal Officer
Common Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Financial Officer
Common Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Common Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
Director
Common Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
Director
Common Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
Director
Common Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
Director
Common Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
Director
Common Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
Director
Common Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Medical Officer | Common SharesGrant or award | 213,900Award · no purchase price | Non-cash award | Jun 30Filed Jul 2 · 2d later | SEC filing |
| Chief Legal Officer | Common SharesGrant or award | 221,100Award · no purchase price | Non-cash award | Jun 30Filed Jul 2 · 2d later | SEC filing |
| Chief Financial Officer | Common SharesGrant or award | 203,700Award · no purchase price | Non-cash award | Jun 30Filed Jul 2 · 2d later | SEC filing |
| Chief Executive Officer | Common SharesGrant or award | 675,000Award · no purchase price | Non-cash award | Jun 30Filed Jul 2 · 2d later | SEC filing |
| Director | Common SharesGrant or award | 45,000Award · no purchase price | Non-cash award | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Common SharesExercise-price or tax withholding | 12,600$3.08 / share | $38.81K | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Common SharesGrant or award | 45,000Award · no purchase price | Non-cash award | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Common SharesExercise-price or tax withholding | 15,196$3.08 / share | $46.8K | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Common SharesGrant or award | 45,000Award · no purchase price | Non-cash award | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Common SharesExercise-price or tax withholding | 12,600$3.08 / share | $38.81K | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Common SharesGrant or award | 45,000Award · no purchase price | Non-cash award | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Common SharesExercise-price or tax withholding | 2,596$3.08 / share | $8K | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Common SharesGrant or award | 45,000Award · no purchase price | Non-cash award | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Common SharesExercise-price or tax withholding | 2,156$3.08 / share | $6.64K | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Common SharesGrant or award | 45,000Award · no purchase price | Non-cash award | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Common SharesExercise-price or tax withholding | 12,600$3.08 / share | $38.81K | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Common SharesGrant or award | 45,000Award · no purchase price | Non-cash award | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Common SharesExercise-price or tax withholding | 12,600$3.08 / share | $38.81K | Jun 3Filed Jun 3 · 0d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
